Table 2 Correlation between unchanged (↔) and increased (↑) post-chemotherapy VEGF expression and clinicopathological parameters; statistics significance p < 0,05 with 1 grade of freedom.
Parameters | VEGF immunostaining after CHT | p | |
|---|---|---|---|
|  | VEGF ↔ | VEGF ↑ |  |
Age | Â | Â | Â |
   ≥ 17 | 1 | 7 |  |
   < 17 | 4 | 4 | p = 0.11 |
Sex | Â | Â | Â |
   Male | 4 | 8 |  |
   Female | 1 | 3 | p = 0.11 |
Site | Â | Â | Â |
   Femur | 2 | 11 |  |
   Other bones | 3 | 0 | p = 0.02 |
Relapse | Â | Â | Â |
   Present | 0 | 5 |  |
   Absent | 5 | 6 | p = 0.04 |
Metastases | Â | Â | Â |
   Present | 1 | 6 |  |
   Absent | 4 | 5 | p = 0.04 |
Survival | Â | Â | Â |
   Dead | 0 | 5 |  |
   Alive | 5 | 6 | p = 0.04 |